ECSP099506A - DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS - Google Patents
DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTSInfo
- Publication number
- ECSP099506A ECSP099506A EC2009009506A ECSP099506A ECSP099506A EC SP099506 A ECSP099506 A EC SP099506A EC 2009009506 A EC2009009506 A EC 2009009506A EC SP099506 A ECSP099506 A EC SP099506A EC SP099506 A ECSP099506 A EC SP099506A
- Authority
- EC
- Ecuador
- Prior art keywords
- quinoxalinona
- quinolinona
- derivatives
- bacterial agents
- anti bacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
La presente invención se refiere a compuestos de Fórmula (I): y sales farmacéuticamente aceptables de los mismos, a su uso en el tratamiento de infecciones bacterianas y a sus métodos de preparación.The present invention relates to compounds of Formula (I): and pharmaceutically acceptable salts thereof, their use in the treatment of bacterial infections and their methods of preparation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87018106P | 2006-12-15 | 2006-12-15 | |
US96916307P | 2007-08-30 | 2007-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099506A true ECSP099506A (en) | 2009-08-28 |
Family
ID=39046831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009506A ECSP099506A (en) | 2006-12-15 | 2009-07-09 | DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP2121702A1 (en) |
JP (1) | JP2010513255A (en) |
KR (1) | KR20090090385A (en) |
AR (1) | AR064369A1 (en) |
AU (1) | AU2007331247B2 (en) |
BR (1) | BRPI0720236A2 (en) |
CA (1) | CA2671485A1 (en) |
CL (1) | CL2007003641A1 (en) |
CO (1) | CO6190619A2 (en) |
EC (1) | ECSP099506A (en) |
MX (1) | MX2009006325A (en) |
NO (1) | NO20092655L (en) |
PE (1) | PE20081511A1 (en) |
RU (1) | RU2009126731A (en) |
TW (1) | TW200831517A (en) |
UY (1) | UY30788A1 (en) |
WO (1) | WO2008071961A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP1900732A4 (en) | 2005-06-24 | 2009-11-18 | Toyama Chemical Co Ltd | Novel nitrogenated heterocyclic compound and salt thereof |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
ES2628091T3 (en) | 2008-10-10 | 2017-08-01 | Idorsia Pharmaceuticals Ltd | Oxazolidinyl antibiotics |
AR076222A1 (en) | 2009-04-09 | 2011-05-26 | Actelion Pharmaceuticals Ltd | DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
WO2012045150A1 (en) * | 2010-10-04 | 2012-04-12 | British Columbia Cancer Agency Branch | Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
WO2019040104A2 (en) * | 2017-08-21 | 2019-02-28 | Acadia Pharmaceuticals Inc. | Compounds, salts thereof and methods for treatment of diseases |
BR112020003477A2 (en) | 2017-08-21 | 2020-08-25 | Acadia Pharmaceuticals, Inc. | compounds and method for treating a disease |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19601265A1 (en) * | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-oxo and 2-thio-1,2-dihydroquinolinyl oxazolidinones |
TW200409637A (en) * | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
WO2006046552A1 (en) * | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | Novel nitrogenous heterocyclic compounds and salts thereof |
MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
EP1900732A4 (en) * | 2005-06-24 | 2009-11-18 | Toyama Chemical Co Ltd | Novel nitrogenated heterocyclic compound and salt thereof |
NZ573032A (en) * | 2006-05-26 | 2010-12-24 | Taisho Pharmaceutical Co Ltd | Antimicrobial heretocyclic compound and intermediates for its production |
EP2029612A1 (en) * | 2006-06-09 | 2009-03-04 | Glaxo Group Limited | Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials |
GB0613208D0 (en) * | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
JP5315239B2 (en) * | 2006-07-20 | 2013-10-16 | グラクソ グループ リミテッド | N-ethylquinolone and derivatives and analogs of N-ethylazaquinolone |
EP1992628A1 (en) * | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
-
2007
- 2007-12-12 TW TW096147437A patent/TW200831517A/en unknown
- 2007-12-13 BR BRPI0720236-9A2A patent/BRPI0720236A2/en not_active IP Right Cessation
- 2007-12-13 WO PCT/GB2007/004766 patent/WO2008071961A1/en active Application Filing
- 2007-12-13 JP JP2009540854A patent/JP2010513255A/en active Pending
- 2007-12-13 CA CA002671485A patent/CA2671485A1/en not_active Abandoned
- 2007-12-13 AU AU2007331247A patent/AU2007331247B2/en not_active Expired - Fee Related
- 2007-12-13 EP EP07848510A patent/EP2121702A1/en not_active Withdrawn
- 2007-12-13 RU RU2009126731/04A patent/RU2009126731A/en not_active Application Discontinuation
- 2007-12-13 MX MX2009006325A patent/MX2009006325A/en not_active Application Discontinuation
- 2007-12-13 KR KR1020097014660A patent/KR20090090385A/en not_active Application Discontinuation
- 2007-12-13 UY UY30788A patent/UY30788A1/en unknown
- 2007-12-14 PE PE2007001798A patent/PE20081511A1/en not_active Application Discontinuation
- 2007-12-14 AR ARP070105641A patent/AR064369A1/en not_active Application Discontinuation
- 2007-12-14 CL CL200703641A patent/CL2007003641A1/en unknown
-
2009
- 2009-07-02 CO CO09068489A patent/CO6190619A2/en not_active Application Discontinuation
- 2009-07-09 EC EC2009009506A patent/ECSP099506A/en unknown
- 2009-07-13 NO NO20092655A patent/NO20092655L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2009006325A (en) | 2009-07-24 |
AU2007331247B2 (en) | 2011-10-20 |
CO6190619A2 (en) | 2010-08-19 |
RU2009126731A (en) | 2011-01-20 |
PE20081511A1 (en) | 2008-12-12 |
WO2008071961A8 (en) | 2009-10-22 |
UY30788A1 (en) | 2008-07-31 |
NO20092655L (en) | 2009-09-02 |
CL2007003641A1 (en) | 2008-09-22 |
AU2007331247A1 (en) | 2008-06-19 |
KR20090090385A (en) | 2009-08-25 |
JP2010513255A (en) | 2010-04-30 |
WO2008071961A1 (en) | 2008-06-19 |
TW200831517A (en) | 2008-08-01 |
BRPI0720236A2 (en) | 2013-12-24 |
AR064369A1 (en) | 2009-04-01 |
EP2121702A1 (en) | 2009-11-25 |
CA2671485A1 (en) | 2008-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32158A (en) | HETEROCICLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
CR11641A (en) | UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME-211 | |
ECSP109903A (en) | DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES | |
CR20140392A (en) | SUBSTITUTED DIHYDROPIRAZOLONES | |
ECSP099506A (en) | DERIVATIVES OF 2-QUINOLINONA AND 2 QUINOXALINONA AND ITS USE AS ANTI BACTERIAL AGENTS | |
UY30759A1 (en) | CHEMICAL COMPOUNDS | |
SV2010003598A (en) | TIAZOL DERIVATIVES USED AS PI 3-CINASA INHIBITORS | |
ECSP10010556A (en) | PIRIDINES AND PIRAZINAS AS PI3K INHIBITORS | |
UY31940A (en) | SUBSTITUTED DERIVATIVES OF 4,5- (SUBSTITUTED-PIRIDIN-3-IL) -1-METHYL-1H-INDOL, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHOS, ROTÁMEROS, PRO-DRUGS, ANANTIOMERS, HYDRATES, SOLVATOS OF THE SAME AND COMPOSITIONS | |
ECSP099750A (en) | IMIDAZOQUINOLINAS WITH IMMUNOMODULATING PROPERTIES | |
EA200870193A1 (en) | CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION | |
EA201200049A1 (en) | 1,3-DESIGNED DERIVATIVES OF IMIDAZOLIDIN-2-IT AS CYP 17 INHIBITORS | |
BRPI0507312A (en) | quinoline derivatives for use as mycobacterial inhibitors | |
CL2011000917A1 (en) | Thioamide derivative compounds; its methods of preparation and use of the compounds for the treatment of endoparasitic diseases. | |
UY29170A1 (en) | REPLACED ADENINS AND USES OF THE SAME | |
UY32315A (en) | PIPERIDINE COMPOUNDS AND USES OF THE SAME-596 | |
UY30544A1 (en) | PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS | |
UY31141A1 (en) | PIPERIDINE COMPOUNDS AND ITS USES | |
UY31864A (en) | DERIVATIVES OF UREA HETERICÍCLICA AND METHODS OF USE OF THE SAME-332 | |
ECSP109900A (en) | USEFUL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS | |
UY31865A (en) | HETEROCYCLIC UREA DERIVATIVES AND METHODS FOR THE USE OF THE SAME | |
UY32674A (en) | UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS | |
UY32856A (en) | UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
UY32694A (en) | UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME | |
UY32316A (en) | USEFUL PIPERIDINE DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS |